Newhall Charles W III
CIK 0001005544
Director
Filings
17
Latest Feb 25, 2026
Issuers covered
1
Showing
17 of 17
Page 1
Track record
7 of 7 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 43% | +0.4% | -0.7% | +8.3% | -6.0% |
| 90 days | 7 | 29% | -1.9% | -2.2% | +1.1% | -3.6% |
| 180 days | 7 | 14% | -5.1% | -3.9% | +12.2% | -14.1% |
| 365 days | 2 | 0% | -26.8% | -26.8% | -25.9% | -27.6% |
Issuers
Companies where Newhall Charles W III has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals, Inc. | 17 | Feb 25, 2026 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|